XML 18 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:    
Revenue $ 210,118 $ 220,382
Operating expenses:    
Cost of product sales, excluding amortization of acquired intangible assets 14,740 14,144
Amortization of intangible assets 51,530 39,415
Research and development 116,129 195,124
Selling, general and administrative 73,272 86,914
Change in the fair value of contingent consideration (100) 2,400
Total operating expenses 255,571 337,997
Loss from operations (45,453) (117,615)
Interest expense, net (40,834) (27,331)
Other income, net 1,591 9,956
Loss before income tax expense (84,696) (134,990)
Income tax expense (6,880) (3,969)
Net loss attributable to common stockholders $ (91,576) $ (138,959)
Weighted-average shares outstanding:    
Basic 76,496,127 73,729,284
Diluted 76,496,127 73,729,284
Net loss per share-basic and diluted (in dollars per share)    
Basic $ (1.20) $ (1.88)
Diluted $ (1.20) $ (1.88)
Net product revenue    
Revenues:    
Revenue $ 177,604 $ 187,557
Collaboration revenue    
Revenues:    
Revenue   6
Royalty revenue    
Revenues:    
Revenue 31,154 30,831
Manufacturing revenue    
Revenues:    
Revenue $ 1,360 $ 1,988